ライフサイエンスコーパス: PVP

1 PVP and CVP were found to be highly correlated (r=0.947)

2 PVP and intracardiac pressures were obtained by transduc

3 PVP can act as a capping and etching agent for protectio

4 PVP images showed a better ability to discriminate the t

5 PVP with well-defined aldehyde and hydroxyl end groups l

6 PVP's high affinity for water and the nifedipine-polymer

7 PVP-AgNPs and AgNO3 both affected pathways involved in N

8 PVP-AgNPs have the potential to cause effects both throu

9 PVP-AuNPs can be a powerful absorber to influence the em

10 PVP-free colloids were also prepared but less stable tha

11 PVP-stabilized NPs in a 10-fold diluted OECD media (chlo

12 PVP/GSNO formulations at doses of 25 and/or 100, but not

13 patients received the intervention (n = 177 PVP vs n = 171 mesh).

14 Reoperation was performed in 19 PVP operated patients (10.7%) versus 7 patients with pol

15 ridyl poly(vinylpyridine) chloride [Os(bpy)2(PVP)10Cl](+) films assembled layer-by-layer with polyion

16 -oxodG) is selectively oxidized by [Os(bpy)2(PVP)10Cl](+) in intact ds-DNA to provide catalytic squar

17 electroluminescent (ECL) polymer ([Ru(bpy)(2)PVP(10)](2+)) were extended to include a fully represent

18 treat [ITT] population; PVP-I/DEX [n = 324]; PVP-I [n = 108]; placebo [n = 321]); mean and standard d

19 ences were seen in recurrences (n = 13, 8.4% PVP vs n = 6, 4.1% mesh, P = 0.127).

20 mesh repair (P = 0.044, 22.1% mesh vs 32.5% PVP).

21 In2 O3 :5%PVP-based transistors exhibit mobilities approaching 11

22 ter, in batch reactors spiked with 5 x 10(6) PVP-nAg particles/mL (10 mug/L), an environmentally rele

23 At a PVP concentration of 100 g/L, the data are consistent wi

24 The presence of a PVP coating on CuNPs has little effect on inhibition.

25 After PVP in 26 (52%) patients, there was a period of increase

26 t of change in pain level and activity after PVP.

27 New vertebral fractures after PVP were clustered within patients and depended heavily

28 Except for Ag-PVP, the affinity of NPs for porous medium, indicated by

29 lidone (PVP) surface ligands and nonideal Ag-PVP-Ag contact at NW-NW junctions.

30 s (NPs) coated with polyvinylpyrrolidone (Ag-PVP) and stabilized by citrate (Ag-CIT) in biofilm-laden

31 Uncharged PVP stabilized Ag-PVP by steric repulsion, and the attachment to glass bea

32 of aqu-nC60, fullerol, and Ag-CIT; while Ag-PVP was again sterically stabilized.

33 ty tests indicate that AgNP-citrate and AgNP-PVP did not exhibit toxicity to the amphipod (Ampelisca

34 r nanoparticles (NPs) (AgNP-citrate and AgNP-PVP) in marine organisms via marine sediment exposure wa

35 virens (N. virens) in the AgNP-citrate, AgNP-PVP and a conventional salt (AgNO3) treatments.

36 ne sediments amended with AgNP-citrate, AgNP-PVP, and AgNO3 was AgCl (50-65%) > Ag2S (32-42%) > Ag me

37 zed), (3) polyvinylpyrrolidone coated AgNPs (PVP-AgNPs) (sterically stabilized), and (4) branched pol

38 AgNO3 and PVP-AgNP exposed fish had common and distinct effects co

39 o common organic capping agents (citrate and PVP) were evaluated.

40 p exposure biomarkers for citrate-coated and PVP-coated AgNPs.

41 METHODS AND PVP-HF (Peripheral Venous Pressure Measurements in Patie

42 ol subjects; (2) overall, PEG, parylene, and PVP produced less histologic disruption than the other t

43 rite induces the degradation of both PES and PVP.

44 e stress markers when compared to saline and PVP groups.

45 on of cediranib in polyvinylpyrrolidone (AZD/PVP) from these devices were achieved.

46 The water-soluble AZD/PVP, which exhibited similar bioactivity as cediranib, w

47 etween PVP and CVP was 0.4 mm Hg and between PVP and pulmonary capillary wedge pressure was 7.5 mm Hg

48 The mean difference between PVP and CVP was 0.4 mm Hg and between PVP and pulmonary

49 The presence of both PVP and Na(2)S facilitate the formation of nanocubes.

50 des effective magnetic actuation, while both PVP and iron oxide have low toxicity.

51 In vivo effects were supported by PVP-AgNP activation of five in vitro nuclear receptor as

52 Ce6-PVP-based fluorescence endoscopy had an improved detecti

53 aluated Chlorin e6 polyvinylpyrrolidone (Ce6-PVP)-based fluorescence endoscopy in comparison to stand

54 nstrate in a proof-of-concept study that Ce6-PVP-based fluorescence endoscopy is a highly sensitive r

55 s beads) and nanoparticle surface chemistry (PVP, citrate, or humic acid) on alpha, and found a stron

56 chloride) beads and beads made from chitosan/PVP (polyvinylpyrrolidone) blend, which resulted in 85.2

57 oated PVC beads and on the beads of chitosan/PVP blend, respectively.

58 In this study, monodisperse citrate, PVP, and PEG coated AgNPs with a core size of approximat

59 on either 70-keV PPP images or conventional PVP images had significantly shorter overall survival co

60 cted protocols: the in-house methods of CTAB-PVP (cetyltrimethylammonium bromide-polyvinylpyrrolidone

61 We demonstrate PVP end-groups induce initial reduction of Ag(+) to form

62 s were randomized 3:1:3 to either PVP-I/DEX, PVP-I alone, or placebo.

63 he safety population treated with PVP-I/DEX, PVP-I, and placebo, respectively (most mild in severity)

64 of the initial Ag(+) reduction at different PVP C(m) and M(w) confirmed the reducing effect originat

65 sed samples were produced by using different PVP chain lengths.

66 network originating from rapidly dissolving PVP plays a key role.

67 ilm by laser dewetting was sprayed with dyed PVP in the SLED mode.

68 njunctivitis were randomized 3:1:3 to either PVP-I/DEX, PVP-I alone, or placebo.

69 As elevated PVP is associated with liver failure after living donor

70 Moreover, excessive PVP interconnect and form PVP-based hydrogels, which lat

71 Following PVP removal, biotinylated thiol and streptavidin protein

72 be 140 and 30 repeating units per nm(2) for PVP of 55,000 and 10,000 g/mol in molecular weight, resp

73 ecies will be harmed ranged from <1 ug/L for PVP-coated n-Ag to >3.5 mg/L for CNTs.

74 )-free nanostars compared with 98 nm/RIU for PVP-coated gold nanostars.

75 oreover, excessive PVP interconnect and form PVP-based hydrogels, which later convert into conductive

76 Free PVP-SE1 phages in solution showed the ability to recogni

77 eedle used in this study was fabricated from PVP and methacrylic acid, using the lithography method.

78 gly, physical mixture containing furosemide, PVP K12 and SDS produced a similar level of oral exposur

79 andard ferri/ferrocyanide is achieved on a G/PVP/PANI-modified electrode with a 3-fold increase in th

80 The droplet-like nanostructures of G/PVP/PANI-modified electrodes are obtained with an averag

81 cholesterol oxidase (ChOx) is attached to G/PVP/PANI-modified electrode for the amperometric determi

82 ing network to render the resultant graphene-PVP thin film conductive, which varies in presence of hu

83 In the majority of European hospitals PVP-iodine-alcohol is still standard of care to prepare

84 We confirm that HPMA, PVP, PMOX, PDMA and PAcM modified liposome have increase

85 humidity due to swelling of the hygroscopic PVP host.

86 Ca(NO3)2 and showed no discernible change in PVP-nAg transport behavior in the presence of 1 to 100 m

87 erage density of PVP from the differences in PVP concentration and the total surface area of Ag nanoc

88 normal pancreas); 2) maximum enhancement in PVP that gradually decreases in DP (type 2 pattern: mild

89 n of CRC, IBD and NTC on CT, particularly in PVP images.

90 Major hepatectomy increased PVP by 26.9% (P = 0.001), markedly decreased HAF by 40.7

91 Intraoperative PVP kinetics serve as independent predictive biomarker o

92 ivariate analysis revealed an intraoperative PVP increase as an independent predictor of PHLF (P = 0.

93 ol dimethacrylate and triallyl isocyanurate, PVP-DEGMA-TAIC; and poly(acrylamide-co-ethylene glycol-d

94 ransformation products resulting from 40 kDa PVP-coated silver nanoparticles (AgNPs) reacted in aerat

95 nhibitors increasing in effectiveness, PEO < PVP < PVCap < VIMA, have increasingly negative (exotherm

96 Median PVP was 9.5 (6-17) mm Hg, CVP was 8.5 (6-18) mm Hg, and

97 (poly[N-(2-hydroxypropyl) methacrylamide]), PVP (poly(vinylpyrrolidone)), PMOX (poly(2-methyl-2-oxaz

98 he PVP-Au seeds, produced by directly mixing PVP with HAuCl4, were able to catalyze H2O2 to enlarge A

99 the luminal membrane surface displayed more PVP than PS.

100 pyrrolidone)-stabilized silver nanoparticle (PVP-nAg) in columns packed with water-saturated quartz s

101 ylpyrrolidone)-protected gold nanoparticles (PVP-AuNPs) and fluorescent BSA-protected gold nanocluste

102 inylpyrrolidone-coated silver nanoparticles (PVP-AgNPs) cause effects through intact nanoparticles or

103 rrolidone (PVP) coated silver nanoparticles (PVP-AgNPs) on the composting of municipal solid waste.

104 The new PVP capped CoFe2O4@CdSe with core-shell nanostructure wa

105 The freeze-dried capsule, 10%w/w nifedipine/PVP, had the highest dissolution rate constant of 0.37 +

106 study clearly shows that small AgNPs (5 nm, PVP and Tan) dissolve rapidly and almost completely, whi

107 By adjusting the In2 O3 :PVP weight ratio, crystallization is frustrated, and con

108 urface plasmon resonance (SPR) absorption of PVP-AuNPs and the excitation of BSA-AuNCs.

109 The SPR absorption of PVP-AuNPs was enhanced with an increased concentration o

110 The addition of PVP as hydrophilic modifier to polysulfone-based membran

111 essed, it was concluded that the addition of PVP in a PLGA matrix resulted in vivo in a more sustaine

112 terestingly, the presence of small amount of PVP (2 mg mL(-1)) in the nanocomposites can substantiall

113 dy, we further illustrate the application of PVP for the interpretation of whole exome sequencing dat

114 rt failure syndromes, a simple assessment of PVP demonstrates a high correlation with CVP.

115 ing also resulted in earlier breakthrough of PVP-nAg compared to younger biofilm coatings, or to the

116 ent shapes depending on the concentration of PVP in the solution.

117 to grow at a fixed initial concentration of PVP to find out when {111} facets started to appear on t

118 to grow at reduced initial concentrations of PVP to see at which concentration {111} facets started t

119 were used to determine the optimal cutoff of PVP and independent risk factors of PLF.

120 We could calculate the coverage density of PVP from the differences in PVP concentration and the to

121 We derived the coverage density of PVP on Ag(100) surface by combining the results from two

122 gNPs and Citrate-AgNPs but the deposition of PVP-AgNPs followed the same order of the electrostatical

123 developed for the environmental detection of PVP AgNPs; although further verification under different

124 characterize the bioaccumulation dynamics of PVP-, PEG-, and citrate-AgNPs, in comparison to dissolve

125 e formation of Ag nanocubes as a function of PVP monomer concentration (C(m)) and molecular weight (M

126 vity and amenability to functionalization of PVP-free gold nanostars should prove useful in applicati

127 trifluoroethanol (TFE) for the generation of PVP/TFE pockets on the surface of a PCL jet.

128 N-H group of nifedipine and the C=O group of PVP was observed and this interaction inhibited nifedipi

129 lar weight (M(w)) demonstrated end groups of PVP impact the final Ag product.

130 , which received intragingival injections of PVP; saline; or PVP/GSNO solutions which corresponded to

131 o either 4.8 mug/L of AgNO3 or 61.4 mug/L of PVP-AgNPs for 96h.

132 ments) with an intraoperative measurement of PVP at the end of the procedure were included.

133 Intraoperative modulation of PVP would be advisable when PVP exceeds 20 mm Hg.

134 ability is caused by the polymeric nature of PVP and that the degree of stabilization depends on both

135 We demonstrate the performance of PVP in identifying causative variants on a large number

136 ices with opposite senses in the presence of PVP but the same sense in the presence of D-sorbitol.

137 The presence of PVP prevents interaction of the Pt nanoparticles with th

138 vide direct evidence for the preservation of PVP-coatings in the presence of Na2S and fulvic acid, wh

139 skin was attained by optimizing the ratio of PVP to methacrylic acid.

140 ion of nanoscale grooves upon the removal of PVP.

141 indicated significantly reduced retention of PVP-nAg at low IS compared to clean sand, irrespective o

142 The decreased retention of PVP-nAg in biofilm-coated sand compared to clean sand is

143 ed a quantitative description of the role of PVP in nanoparticle shape-control and demonstrates a uni

144 improved by 150-times compared with that of PVP-wrapped ones.

145 iated infections, suggesting that the use of PVP-iodine should be reevaluated for disinfection of the

146 P in 25/25 patients (sensitivity = 100%), on PVP in 22/25 (sensitivity = 88%) and on DP in 20/25 (sen

147 in 31/38 patients (sensitivity = 81.6%), on PVP in 29/38 (sensitivity = 76.3%) and on DP in 17/38 (s

148 ence stability of these suspensions based on PVP morphological changes at different pH values.

149 do not cause an ABC effect such as, HPMA or PVP, deserve further consideration as polymer coatings t

150 days and was slower compared to pure PCL or PVP.

151 intragingival injections of PVP; saline; or PVP/GSNO solutions which corresponded to GSNO doses of 2

152 dation of 1-thioglycerol (TG) mediated by Os-PVP complex on the surface of graphite electrode at appl

153 polyvinylpyridine bearing osmium complex (Os-PVP).

154 odified with a conductive osmium polymer (Os-PVP) complex were employed to quantify resulting CdS QDs

155 d with patch repair (PROCEED Ventral Patch) (PVP).

156 Release of antibiotic from PCL-PVP dosage forms was shown over 5 days and was slower co

157 of binding of four inhibitor molecules (PEO, PVP, PVCap, and VIMA) to a hydrate surface is estimated

158 with ultrafiltration and nanofiltration PES/PVP membranes for various aging times.

159 egarding the mechanism of degradation of PES/PVP membranes by sodium hypochlorite.

160 d by a rapid decline on portal venous phase (PVP) and delayed phase (DP) at 5 minutes (type 1 pattern

161 nsity (MD) images, plus portal venous phase (PVP) conventional CT images.

162 rterial phase (AP), and portal venous phase (PVP) scans.

163 rterial phase (HAP) and portal venous phase (PVP).

164 ding X 3Si-R-SiX 3 with poly(4-vinyl)phenol (PVP) require very low-curing temperatures ( approximatel

165 l to acquire a pulse volume plethysmography (PVP) waveform and calibrate it to brachial BP levels est

166 Solid dispersions, based on a PLGA/PVP matrix, were compared to solid dispersions in a pure

167 based on the structure of these binary PLGA/PVP matrices where the pore network originating from rap

168 prised of the commercially available polymer PVP = poly(4-vinylpyridine) and the Au(I) precursors [Au

169 dine)Os(bipyridyl)2Cl(2+/3+)] redox polymer (PVP-Os) through a layer-by-layer (LBL) self-assembly pro

170 coatings, citrate and polyvinylpirrolidone (PVP), and prepared nanoparticle suspensions (approximate

171 coatings, citrate and polyvinylpirrolidone (PVP), both showed strong interactions with ferbam and in

172 o separate 40 nm sized polyvinylpirrolidone (PVP)- and citrate-coated NPs, 40 nm sized polyethylene g

173 m arabic (GA-AgNPs) or polyvinylpyrollidone (PVP-AgNPs), as well as AgNO(3).

174 rd inorganic salts and polyvinylpyrrolidine (PVP(55000)) stabilizers.

175 Polyvinylpyrrolidone (PVP), a thermoplastic polymer is sprayed below its glass

176 we sample and analyze polyvinylpyrrolidone (PVP) and the IR spectrum measured by photothermal spectr

177 ylcellulose (HPMC) and polyvinylpyrrolidone (PVP) and sectioning using a cryomicrotome.

178 nanoplates (NPLs) and polyvinylpyrrolidone (PVP) by using Au nanoparticles as concentration referenc

179 of gum arabic (GA) and polyvinylpyrrolidone (PVP) coated Ag nanoparticles (NPs) in aquatic microcosms

180 rmation of citrate and polyvinylpyrrolidone (PVP) coated silver nanoparticles (NPs) (AgNP-citrate and

181 f polysulfone (PS) and polyvinylpyrrolidone (PVP), were investigated, regarding chemical structure an

182 xicity of uncoated and polyvinylpyrrolidone (PVP)-coated CuO, and Cu2O nanoparticles, as well as Cu i

183 , gum arabic (GA), and polyvinylpyrrolidone (PVP).

184 CuO NPs that are polyvinylpyrrolidone (PVP)-coated with a greater stability against aggregation

185 were also considered: polyvinylpyrrolidone (PVP), tannic acid (Tan), and citric acid (Cit).

186 ons of GSNO-containing polyvinylpyrrolidone (PVP) formulations is evaluated in a rat model of periodo

187 ted to the ill-defined polyvinylpyrrolidone (PVP) surface ligands and nonideal Ag-PVP-Ag contact at N

188 0 nm) containing drug, polyvinylpyrrolidone (PVP) K12 and sodium dodecyl sulfate (SDS) in 1:2.75:0.25

189 the release of Ag from polyvinylpyrrolidone (PVP)- and citrate-coated 80 nm nAg in aerobic WW effluen

190 osite of graphene (G), polyvinylpyrrolidone (PVP) and polyaniline (PANI) has been successfully prepar

191 lymer concentration in polyvinylpyrrolidone (PVP) and Ficoll solutions of different molecular weights

192 ns and distribution of polyvinylpyrrolidone (PVP) and citrate (CT) coated AgNPs in boreal lake mesoco

193 the multiple roles of polyvinylpyrrolidone (PVP) and their dependence on other factors.

194 valuates the impact of polyvinylpyrrolidone (PVP) coated silver nanoparticles (PVP-AgNPs) on the comp

195 m inhibitory effect of polyvinylpyrrolidone (PVP)-coated AgNPs were evaluated in bench-scale moving b

196 at aim, suspensions of polyvinylpyrrolidone (PVP)-coated ceria nanoparticles (NPs) were produced.

197 y(ether sulfone) (PES)/polyvinylpyrrolidone (PVP) membranes are widely used in various industrial fie

198 LGA) and water-soluble polyvinylpyrrolidone (PVP) was evaluated.

199 nts (tannic acid (TA), polyvinylpyrrolidone (PVP), branched polyethylenimine (BPEI), polyethylene gly

200 of 474 nm/RIU for the polyvinylpyrrolidone (PVP)-free nanostars compared with 98 nm/RIU for PVP-coat

201 erence MC252 oil using polyvinylpyrrolidone (PVP)-coated iron oxide nanoparticles (NPs) from oil-wate

202 as examined in viscous polyvinylpyrrolidone (PVP) solutions at 28 and at 37 degrees C, using fluoresc

203 fter disinfection with polyvinylpyrrolidone (PVP or povidone)-iodine-alcohol and the correlation with

204 pyrrolidone [NEP], and polyvinylpyrrolidone [PVP]) on protein stability.

205 or citrate- (cit) and polyvinylpyrrolidone- (PVP) capped silver nanoparticles (AgNPs), in the presenc

206 u and Ag stabilized by polyvynylpyrrolidone (PVP).

207 andomized (intent-to-treat [ITT] population; PVP-I/DEX [n = 324]; PVP-I [n = 108]; placebo [n = 321])

208 er changing viscosities, along with possible PVP-mediated crowding effects, may explain the observed

209 safety was evaluated with review of all post-PVP complications and their treatment.

210 mutagenesis to the S4-S5 linker and the post-PVP S6 segment, and conducted electrophysiological analy

211 Posthepatectomy PVP is an independent predictive factor of PLF and of 90

212 Posthepatectomy PVP was gradually correlated with the PLF risk.

213 At multivariate analysis, posthepatectomy PVP remained an independent predictor of PLF as well as

214 tectomy may be influenced by posthepatectomy PVP.

215 The optimal value of posthepatectomy PVP to predict PLF was 22 mm Hg when considering the "50

216 amics rather than the pre- and postresection PVP values.

217 c vein resection caused higher postresection PVP after right hepatectomy (P = 0.04), the Pringle mane

218 emonstrate the PhenomeNET Variant Predictor (PVP) system that exploits semantic technologies and auto

219 ought to compare peripheral venous pressure (PVP) with central venous pressure (CVP), as well as othe

220 Portal venous pressure (PVP), IHR, plasma and hepatic levels of various substanc

221 Portal venous pressure (PVP), portal venous flow (PVF), and hepatic arterial flo

222 in the conserved Kv proline-valine-proline (PVP) motif, Cd(2+) forms intrasubunit coordination with

223 polymer (polystyrene-b-polyvinylpyridine, PS-PVP) and a hydrogen-bonding agent (HA) enables formation

224 lycaprolactone (PCL), polyvinyl pyrrolidone (PVP) and their composite system (PVP-PCL).

225 l alcohol (IPA) using polyvinyl pyrrolidone (PVP) polymer as the stabilizer.

226 ained with the aid of polyvinyl pyrrolidone (PVP).

227 in the presence of poly(vinyl pyrrolidone) (PVP) and a trace amount of Na(2)S.

228 ectly mixed 20% w/v poly(vinyl pyrrolidone) (PVP) gel, with the mixture filled into laser engineered

229 in the presence of poly(vinyl pyrrolidone) (PVP) has recently been demonstrated as a convenient meth

230 olactone) (PCL) and poly(vinyl pyrrolidone) (PVP) in 2,2,2-trifluoroethanol (TFE) for the generation

231 bon (AC), parylene, poly(vinyl pyrrolidone) (PVP), or poly(ethylene glycol) (PEG) were each implanted

232 trate (Na(3)CA) and poly(vinyl pyrrolidone) (PVP), respectively, as a capping agent while all other p

233 with biocompatible poly(vinyl pyrrolidone) (PVP), which can be polymerized in situ to entrap the SWN

234 ter treatment plant (WWTP) that had received PVP coated 50 nm Ag NPs and 30 nm ZnO NPs, dissolved met

235 a system comprising poly(vinylpyrrolidone)s (PVPs) of varying molecular weights as crowding agents an

236 edral seeds themselves, both having the same PVP capping agent.

237 EG)- and citrate-coated NPs, and 60 nm sized PVP- and citrate-coated NPs.

238 sized citrate-coated and 40 and 60 nm sized PVP-coated NPs, could be distinguished.

239 nt-derived DOM had the effect of stabilizing PVP-AgNPs as primary particles, but caused GA-AgNPs to b

240 In this study, PVP-I/DEX did not demonstrate additional benefit in clin

241 yrrolidone (PVP) and their composite system (PVP-PCL).

242 sociated with a lower complication rate than PVP repair.

243 reased circulation times in rodents and that PVP, PDMA, and PAcM do not induce the ABC effect.

244 Our data provide clear evidence that PVP-iodine-alcohol is effective for preparation of the p

245 We find that PVP accurately identifies causative variants in whole ex

246 We also observed that PVP- and Tan-AgNPs are more prone to Ag(+) release than

247 The results suggest that PVP K12 and SDS were able to increase the furosemide fre

248 These findings suggest that PVP may be useful in the standard bedside clinical asses

249 The PVP layer provides a high density of proton-accepting py

250 The PVP was also found to be partly released from the membra

251 The PVP-AgNPs breakthrough occurred more rapid as compared t

252 The PVP-Au seeds, produced by directly mixing PVP with HAuCl

253 t during the HAP (-25.3%, P < .0001) and the PVP (-22.4%, P < .0001) in all patients.

254 ual residue in the protein structure and the PVP concentration.

255 o repulsive electrosteric forces between the PVP coatings and extracellular polymeric substances (EPS

256 DNA damage repair genes were induced by the PVP AgNPs, but not the other treatments.

257 ring the HAP or of 50% or greater during the PVP.

258 ired method was then employed to extract the PVP waveform from the same waveform via ensemble averagi

259 achieved by 50.5% (111/220) subjects in the PVP-I/DEX group vs 42.8% (95/222) in the placebo group (

260 However, removal of the PVP with UV light results in a 50-fold enhancement in th

261 ally, the slope of the rising portion of the PVP-nAg breakthrough curve was noticeably steeper in bio

262 ) treatment process to thoroughly remove the PVP ligands and produce a clean Ag-Ag interface that all

263 were also prepared but less stable than the PVP-protected NPs.

264 l characterization studies indicate that the PVP-nAg is stable in suspension and exhibits little chan

265 combining the dual-energy CT values with the PVP values and as individual predictors.

266 CPB film quality is correlated with the PVP-cross-linking reagent reactivity.

267 ock-triggered proton transfer from phenol to PVP.

268 for citrate-coated nanoparticles relative to PVP-coated nanoparticles.

269 Uncharged PVP stabilized Ag-PVP by steric repulsion, and the attac

270 A total of 115 patients who underwent PVP for 216 painful long-standing OVCFs were prospective

271 Patches prepared using PVP and TE-HCL displayed enhanced hydrophobicity.

272 ate of SSIs of 4.04% was achieved when using PVP-iodine-alcohol for disinfection of the preoperative

273 enced by the weight ratio of NMP and 20% w/v PVP.

274 doping In2 O3 films with poly(vinylphenole) (PVP).

275 icrobeads coated with poly(2-vinylpyridine) (PVP).

276 In blends with poly(4-vinylpyridine) (PVP) and phenol, NR showed an excess shock-induced red-s

277 diators are made of a poly(4-vinylpyridine) (PVP) polymer with Os complexes tethered to the polymer b

278 reducing agent and poly(N-vinylpyrrolidone) (PVP) the shape-directing agent.

279 hin thin shells of poly(N-vinylpyrrolidone) (PVP), which leads to significantly improved protein stab

280 on using sulfur and poly(vinylpyrrolidone) (PVP) as catalytic promoters carried out in the author's

281 f the role played by poly(vinylpyrrolidone) (PVP) in seed-mediated growth of Ag nanocrystals.

282 of additives such as poly(vinylpyrrolidone) (PVP) or D-sorbitol, form ring-banded spherulites compose

283 gradation within the poly(vinylpyrrolidone) (PVP) polymer matrix.

284 ions of the cosolute poly(vinylpyrrolidone) (PVP) that mimic the protein concentration in cells.

285 ulated in a layer of poly(vinylpyrrolidone) (PVP).

286 tide bonds within the consensus sequence VNP PVP.

287 ons for all but the highest-molecular-weight PVP can be described in detail by Newtonian hydrodynamic

288 nian effects in the highest-molecular-weight PVP solution.

289 n PVP was 20 mm Hg, and from 24% to 33% when PVP was 30 mm Hg.

290 ve modulation of PVP would be advisable when PVP exceeds 20 mm Hg.

291 % to 16%, depending on PLF definitions, when PVP was 20 mm Hg, and from 24% to 33% when PVP was 30 mm

292 Probability for PLF was nil when PVP was 10 mm Hg or less, ranges from 13% to 16%, depend

293 While PVP-AgNPs were quite stable and resisted transformation

294 und to be highly correlated (r=0.947), while PVP and pulmonary capillary wedge pressure were found to

295 he influence of the two capping agents, with PVP-AgNPs showing few or no significant changes in appar

296 The 90-day mortality was associated with PVP greater than 21 mm Hg, older than 70 years, and intr

297 al counts were taken after disinfection with PVP-iodine-alcohol, immediately before incision.

298 bjects in the safety population treated with PVP-I/DEX, PVP-I, and placebo, respectively (most mild i

299 ose oxidase (GOx), electrically "wired" with PVP-[Os(N,N'-dimethyl-2,2'-biimidazole)(3)](2+/3+) (poly

300 done), Wizard with and without RNase, Wizard-PVP with and without RNase, and the Wizard Magnetic and